title: [Severe haemoptysis: indications for triage and admission to hospital or intensive care unit].
abstract: Recognition of the criteria of severity and the early admission to a referral center play a critical role in the prognosis of severe haemoptysis. The therapeutic management should be undertaken urgently by providing general supportive care, i.e., optimization of oxygenation and haemodynamic stabilization to prevent recurrence of massive bleeding. Interventional radiology has dramatically improved the initial management of severe haemoptysis. Attempts to control haemoptysis by first-line non-surgical methods are necessary to optimize the operative conditions and improve morbidity and mortality. Surgical lung resection remains the treatment of choice in selected patients with localized lesions complicated by severe and/or recurrent episodes of haemoptysis (bronchiectasis) or lesions associated with a high risk of recurrence of bleeding (mycetoma). Haemoptysis related to pulmonary arterial involvement remains a surgical emergency.
authors.affiliation: Service de Pneumologie et Réanimation, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Université Pierre-et-Marie-Curie, 4 Rue de la Chine, 75020 Paris, France. muriel.fartoukh@tnn.aphp.fr
authors.forename: M
authors.initials: M
authors.lastname: Fartoukh
mesh_terms: D001984:Bronchial Neoplasms / Q000150:complications; D001987:Bronchiectasis / Q000150:complications; D003131:Combined Modality Therapy; D015897:Comorbidity; D003952:Diagnostic Imaging; D004630:Emergencies; D006469:Hemoptysis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D006489:Hemostatic Techniques; D006490:Hemostatics / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D007362:Intensive Care Units; D008271:Mycetoma / Q000150:complications; D010343:Patient Admission; D011379:Prognosis; D011651:Pulmonary Artery / Q000601:surgery; D015642:Radiology, Interventional; D012008:Recurrence; D014218:Triage; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
chemical_list: D006490:Hemostatics; D014662:Vasoconstrictor Agents